Displaying One Session

Time
08:45 - 09:45

Welcome and introduction (ID 4691)

Recent advances in ALK+ NSCLC (ID 4692)

Treatment selection and sequencing: decision making in 2021 (ID 4693)

The importance of managing CNS disease (ID 4694)

Optimising patient outcomes: treatment management options (ID 4695)

Q+A session (ID 4696)

Wrap up and close (ID 4697)